findmyKOL
Clinical trialNCT03377803CompletedPhase 3Interventional

Cantharidin Application in Molluscum Patients

SponsorVerrica Pharmaceuticals Inc.Enrollment262Molluscum Contagiosum
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This study is a Phase 3, randomized, double-blind, placebo-controlled, pivotal study to evaluate the safety and efficacy of VP-102 topical film-forming solution in subjects with Molluscum Contagiosum. VP-102 will be applied once every 21 days for up to 4 applications, to treatable molluscum contagiosum (molluscum) lesions on subjects 2 years and older. Efficacy will be assessed as the proportion of subjects achieving complete clearance of all treatable molluscum lesions (baseline and new) on the Day 84 visit.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

15 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Bakersfield Dermatology

    Bakersfield, California, United States

  • Rady Children'S Hospital

    San Diego, California, United States

  • Redwood Family Dermatology

    Santa Rosa, California, United States

  • Solution Through Advanced Research

    Jacksonville, Florida, United States

  • Lenus Research and Medical Group

    Sweetwater, Florida, United States

  • Northwestern Memorial Hospital

    Chicago, Illinois, United States

  • Dermatology Center of Northwestern Indiana

    Crown Point, Indiana, United States

  • Pedia Research

    Evansville, Indiana, United States

  • Pedia Research

    Owensboro, Kentucky, United States

  • Hamzavi Dermatology

    Fort Gratiot, Michigan, United States

  • Midwest Children'S Health

    Lincoln, Nebraska, United States

  • Midwest Children'S Health-Northwoods

    Lincoln, Nebraska, United States

  • Tekton Research

    Austin, Texas, United States

  • Dcol Center for Clinical Research

    Longview, Texas, United States

  • the Education and Research Foundation

    Lynchburg, Virginia, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
14 Feb 2018
Primary completion
26 Sept 2018
Completion
26 Sept 2018
Last update posted
14 Dec 2021
Registered enrollment
262
Registry id
NCT03377803
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.